Chunlei Han

Title: Inventor Chunlei Han: Innovating Cancer Treatments

Introduction

Chunlei Han, based in Beijing, China, is an accomplished inventor with a focus on pharmaceutical innovations. He has secured one notable patent that promises advancements in the treatment of various disease states, including cancer and inflammatory conditions. Han's contributions exemplify the critical intersection of scientific research and practical applications in medicine.

Latest Patents

Chunlei Han's patent, titled "Polymorphs of CDDO ethyl ester and uses thereof," relates to the polymorphic forms of the compound ethyl 2-cyano-3,12-dioxo-leana-1,9(11)-dien-28-oate, commonly known as CDDO ethyl ester. This invention outlines methods for employing these polymorphs in treating a variety of diseases, showcasing significant potential for enhancing therapeutic efficacy in oncology and inflammatory disorders.

Career Highlights

Currently, Chunlei Han is affiliated with Applied Pharmaceutical Science, Inc., a company dedicated to advancing pharmaceutical solutions. His role at the firm enables him to leverage his expertise in developing innovative drug formulations. This pursuit reflects a commitment to addressing complex medical challenges through scientific ingenuity.

Collaborations

Chunlei Han collaborates closely with fellow researchers Xiaohong Zhang and Lu Song. Their collective efforts contribute to the ongoing research and development of new pharmaceutical therapies, emphasizing the importance of teamwork in achieving innovative breakthroughs in the medical field.

Conclusion

Chunlei Han represents the spirit of innovation within the pharmaceutical industry, with his work primarily focused on improving treatments for serious health conditions. His developments not only advance scientific knowledge but also hold promise for delivering effective solutions to patients in need. Through his patent and ongoing collaborations, he continues to make valuable contributions to medical science and patient care.